Health Affairs, 27, no. 4 (2008): w260-w269 (Published online 28 May 2008) doi: 10.1377/hlthaff.27.4.w260 © 2008 by Project HOPE	New Online   Obama's Success & Next Steps   3 Health Policy Options for President Obama   A Hybrid Proposal   Bipartisan Compromise

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Google Scholar Articles by Kim, H.-J. Articles by Ruger, J. P. PubMed PubMed Citation Articles by Kim, H.-J. Articles by Ruger, J. P. Related Collections Access To Care Health Reform International Issues Business Of Health Pharmaceuticals Physicians Health Spending Consumer Issues

Web Exclusives

MARKETWATCH

Pharmaceutical Reform In South Korea And The Lessons It Provides

Through implementation of its 2000 pharmaceutical reform, the South Korean government expected to reduce the cost of medications and improve service levels, medical appropriateness of care, and drug effectiveness. However, despite the reform’s lofty goals, unintended consequences have distorted the supply of medical services and spending. These consequences have included increasing the use of uninsured services, prescribing high-price drugs, and a growing market share for multinational drug companies. Further reforms are needed to reduce the measure’s adverse effects. This paper examines the Korean mandatory prescription system and offers an analysis of Korea’s reforms.

                      What's this?